PROTEAN.BO(PROTEAN.BO)
PROTEAN.BO
No analyst ratings available
No analyst price targets available for PROTEAN.BO
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $11.32B | $12.33B |
| Low | $11.30B | $11.92B |
| High | $11.34B | $12.70B |
| EBITDA Avg | $2.22B | $2.42B |
| Low | $2.21B | $2.33B |
| High | $2.22B | $2.49B |
| EBIT Avg | $1.85B | $2.02B |
| Low | $1.85B | $1.95B |
| High | $1.86B | $2.08B |
| Net Income Avg | $1.29B | $1.40B |
| Low | $1.26B | $1.24B |
| High | $1.32B | $1.53B |
| EPS Avg | $31.70 | $34.40 |
| Low | $30.93 | $30.46 |
| High | $32.47 | $37.69 |
| Analysts (Rev / EPS) | 2 / 2 | 3 / 3 |